Genomma Lab Internacional, S.A.B. de C.V. Stock
Stocks
LAB B
MX01LA010006
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.95 MXN | -0.86% |
|
-0.93% | -16.43% |
| Market Cap | 14.58B 836M 731M 676M 620M 1.17B 80.57B 1.19B 8.06B 3.17B 39.34B 3.14B 3.07B 136B | P/E 2026 * |
7.24x | P/E 2027 * | 6.74x |
|---|---|---|---|---|---|
| Enterprise Value | 18.44B 1.06B 924M 855M 784M 1.48B 102B 1.51B 10.2B 4.01B 49.76B 3.97B 3.88B 172B | EV / Sales 2026 * |
1.01x | EV / Sales 2027 * | 0.92x |
| Free-Float |
68.95% | Yield 2026 * |
5.36% | Yield 2027 * | 7.34% |
Last Transcript: Genomma Lab Internacional, S.A.B. de C.V.
| 1 day | -0.86% | ||
| 1 week | -0.93% | ||
| Current month | -0.53% | ||
| 1 month | +1.56% | ||
| 3 months | -16.99% | ||
| 6 months | -14.57% | ||
| Current year | -16.43% |
| 1 week | 14.63 |  | 15.49 |
| 1 month | 14.24 | | 15.7 |
| Current year | 14.24 | | 19.48 |
| 1 year | 14.24 | | 23.6 |
| 3 years | 12.39 | | 29.18 |
| 5 years | 12.39 | | 29.18 |
| 10 years | 11.1 | | 29.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | 12/04/2023 |
| Director of Finance/CFO | - | 01/12/2015 | |
| Investor Relations Contact | - | 01/10/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/10/1996 | |
Juan Alonso
BRD | Director/Board Member | - | 06/07/2010 |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.86% | -0.93% | -26.10% | +9.36% | 839M | |
| +1.43% | -3.56% | +48.60% | +162.47% | 1,031B | |
| +0.93% | -3.63% | +51.53% | +56.97% | 595B | |
| +3.67% | +1.39% | +32.95% | +87.93% | 431B | |
| +0.42% | -0.99% | +30.04% | +22.27% | 326B | |
| +1.03% | -2.10% | +28.32% | +45.08% | 277B | |
| +0.49% | -5.44% | +21.00% | +23.80% | 263B | |
| +1.59% | +3.91% | -22.47% | -36.84% | 224B | |
| +2.98% | +2.11% | +24.17% | +62.97% | 193B | |
| +4.29% | +0.99% | +23.96% | +75.76% | 164B | |
| Average | +1.51% | -3.53% | +21.20% | +50.98% | 350.51B | |
| Weighted average by Cap. | +1.59% | -4.31% | +34.72% | +80.37% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 18.26B 1.05B 915M 846M 777M 1.47B 101B 1.5B 10.09B 3.97B 49.27B 3.93B 3.85B 170B | 19.58B 1.12B 981M 908M 833M 1.58B 108B 1.6B 10.82B 4.25B 52.83B 4.22B 4.12B 182B |
| Net income | 2.05B 117M 103M 94.83M 87.02M 165M 11.3B 168M 1.13B 444M 5.52B 441M 431M 19.06B | 2.25B 129M 113M 104M 95.75M 181M 12.44B 184M 1.24B 489M 6.07B 485M 474M 20.97B |
| Net Debt | 3.86B 221M 194M 179M 164M 311M 21.34B 316M 2.14B 839M 10.42B 832M 813M 35.98B | 3.46B 199M 174M 161M 147M 279M 19.14B 284M 1.91B 752M 9.35B 746M 730M 32.27B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | MX$14.95 | -0.86% | 3,049,369 |
| 14/07/26 | MX$15.08 | -0.33% | 4,242,868 |
| 13/07/26 | MX$15.13 | -0.66% | 2,935,770 |
| 10/07/26 | MX$15.23 | +0.66% | 3,153,031 |
| 09/07/26 | MX$15.13 | +0.27% | 3,238,203 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LAB B Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
